- Release Date: 10/02/20 08:21
- Summary: Mayo Clinic clinical study to evaluate HeraBEAT Plus
- Price Sensitive: No
- Download Document 126.15KB
- Forums
- ASX - By Stock
- Ann: Mayo Clinic clinical study to evaluate HeraBEAT Plus
HMD
heramed limited
Add to My Watchlist
5.88%
!
3.6¢

Ann: Mayo Clinic clinical study to evaluate HeraBEAT Plus
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
3.6¢ |
Change
0.002(5.88%) |
Mkt cap ! $37.47M |
Open | High | Low | Value | Volume |
3.5¢ | 3.6¢ | 3.5¢ | $67.09K | 1.901M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 466991 | 3.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
3.8¢ | 655000 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 305981 | 0.035 |
3 | 1235162 | 0.034 |
1 | 1000000 | 0.033 |
2 | 2000000 | 0.032 |
3 | 1586431 | 0.030 |
Price($) | Vol. | No. |
---|---|---|
0.036 | 40000 | 2 |
0.037 | 47650 | 1 |
0.038 | 155000 | 2 |
0.039 | 348333 | 2 |
0.040 | 112000 | 2 |
Last trade - 16.10pm 16/09/2025 (20 minute delay) ? |
Featured News
HMD (ASX) Chart |